[시장보고서]면역조직화학(IHC) 시장 규모, 점유율, 예측, 동향 분석 : 제품별(시약[고정, 완충액, 차단, 항체]), 키트별, 장비별[염색, 이미징], 방법 프로세스별, 용도별, 최종사용자별

면역조직화학(IHC) 시장 규모, 점유율, 예측, 동향 분석 : 제품별(시약[고정, 완충액, 차단, 항체]), 키트별, 장비별[염색, 이미징], 방법 프로세스별, 용도별, 최종사용자별 - 세계 예측(-2031년)

Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends Analysis by Offering (Reagents [Fixation, Buffer, Blocking, Antibodies]), Kits, Equipment [Staining, Imaging] Method Process, Application, End User - Global Forecast to 2031

상품코드 : 1576633

리서치사 : Meticulous Research

발행일 : On Demand Report

페이지 정보 : 영문

라이선스 & 가격 (부가세 별도)

US $ 4,175

￦ 6,032,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회만 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,875

￦ 8,488,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,875

￦ 11,377,000

PDF (Global Site License)

PDF 보고서를 동일 기업 및 자회사의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계 면역조직화학 시장은 2024년부터 2031년까지 7.2%의 CAGR로 2031년까지 40억 8,000만 달러에 달할 것으로 예상됩니다.

이 보고서는 광범위한 2차 및 1차 조사, 시장 시나리오에 대한 심층 분석을 통해 주요 시장 촉진요인, 억제요인, 도전 과제 및 기회 분석으로 구성되어 있습니다. 세계 면역조직화학 시장의 성장은 노인의 만성질환 유병률 증가, 희귀질환에 대한 관심 증가, 조기 진단의 중요성에 대한 인식 증가, R&D 비용 증가, 신약개발 수요 증가, 감염성 질환 부담 증가, 연구 활동에 대한 자금 지원 증가, 의료비 지출 증가 등에 의해 주도되고 있습니다. 주도하고 있습니다. 그러나 표준화된 프로토콜의 부족은 이 시장의 성장을 저해하는 요인으로 작용하고 있습니다.

또한, 맞춤형 의료로의 전환, 유전체학 및 단백질체학 혁신, 조직화학 분야의 자동화 발전은 시장 성장의 기회를 창출할 것으로 예상됩니다. 그러나 대체 기술의 가용성은 세계 면역조직화학 시장에서 큰 도전과제가 되고 있습니다.

개요
성장 촉진요인
- 노인 인구 증가에 따른 만성질환 유병률 상승
- 희귀질환에 대한 주목 상승
- 질환 조기 진단에 관한 인식 확산
- 연구개발비 증가
- Drug Discovery 개발 수요 증가
- 감염증 유행 증가
- 연구 활동에 대한 자금 제공 증가
- 헬스케어 지출 증가
성장 억제요인
- 표준화된 프로토콜의 결여
기회
- 맞춤형 의료에 대한 지향 상승
- 유전체학과 단백질체학의 진보
- 면역조직화학 자동화 증가
과제
- 대체 기술 이용 가능성
동향
- AI 기반 조직화학
- Multiplex IHC 사용
인자 분석
사례 연구
가격 분석
규제 분석
- 미국
- 캐나다
- 유럽
- 중국
- 일본
- 인도
- 라틴아메리카
- 중동
가격 분석
Porter's Five Forces 분석

제5장 면역조직화학 시장 평가 : 제공별

개요
소모품
- 시약
  - 고정 시약
  - 항원 회수 시약
  - 완충액
  - 블로킹 시약
  - 항체
  - 컨트롤 시약
  - 발색 기질
  - 카운터스테인
- 기타 액세서리
장비
- 염색 시스템
- 이미징 시스템
- 슬라이드 스캐너
- 조직 마이크로어레이
서비스·소프트웨어

제6장 면역조직화학 시장 평가 : 방법별

개요
아비딘-바이오틴 복합체
폴리머 기반 면역조직화학
촉매 신호 증폭법(CSA)
형광 티라마이드 증폭법
개량형 촉매 신호 증폭법(iCSA)
다염색 면역조직화학
표지 스트렙타비딘 비오틴(LSAB)
PAP법

제7장 면역조직화학 시장 평가 : 프로세스별

개요
샘플 조제
항원 회수
백그라운드 블록
표적 검출
샘플 가시화

제8장 면역조직화학 시장 평가 : 용도별

개요
연구·기타 용도
- Drug Discovery
- 농업·동물 연구
- 기타 용도
임상 응용
- 생식 의료
- 종양학
- 감염증
- 기타 임상 응용

제9장 면역조직화학 시장 평가 : 최종사용자별

개요
제약·바이오테크놀러지 기업
병원·진단 연구소
학술기관·연구 센터
수탁연구기관
기타 최종사용자

제10장 면역조직화학 시장 평가 : 지역별

개요
북미
- 미국
- 캐나다
유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 기타 아시아태평양
라틴아메리카
- 브라질
- 멕시코
- 기타 라틴아메리카
중동 및 아프리카

제11장 경쟁 분석

개요
주요 성장 전략
경쟁 벤치마킹
경쟁 대시보드
- 업계 리더
- 시장 차별화 요인
- 선행 기업
- 신흥 기업
주요 기업의 시장 점유율 분석/시장 순위(2023년)

제12장 기업 개요(사업 개요, 재무 개요, 제품 포트폴리오, 전략적 전개, SWOT 분석*)

F. Hoffmann-La Roche Ltd(Switzerland)
Danaher Corporation(U.S.)
Agilent Technologies, Inc.(U.S.)
Merck KGaA(Germany)
Bio-Rad Laboratories, Inc.(U.S.)
Eagle Biosciences, Inc.(U.S.)
Thermo Fisher Scientific Inc.(U.S)
Cell Signaling Technology, Inc.(U.S.)
PerkinElmer, Inc.(U.S.)
Bio SB Inc.(U.S.)
Biocare Medical, LLC.(U.S.)
Bio-Genex Laboratories(U.S.)
CANDOR Bioscience GmbH(Germany)
Innovex Biosciences Inc.(U.S.)

(참고 : 상위 5개사 SWOT 분석을 제공합니다)

제13장 부록

ksm

영문 목차

영문목차

Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends Analysis by Offering (Reagents [Fixation, Buffer, Blocking, Antibodies], Kits, Equipment [Staining, Imaging] Method (ABC, CSA, PAP) Process, Application, End User-Global Forecast to 2031

The global immunohistochemistry market is projected to reach $4.08 billion by 2031 at a CAGR of 7.2% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the global immunohistochemistry market is driven by the increasing prevalence of chronic diseases, among geriatric populations, increasing emphasis on rare diseases, growing awareness toward the importance of early disease diagnosis, rising R&D expenditure, growing demand for drug discovery and development, increasing burden of infectious diseases, increasing funding for research activities and rising healthcare expenditure. However, the lack of standardized protocols is restraining the growth of this market.

Furthermore, inclination toward personalized medicine, innovations in genomics and proteomics, and increasing automation in histochemistry are expected to generate market growth opportunities. However, the availability of alternative technologies is a major challenge in the global immunohistochemistry market.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the past three to four years. The key players operating in the immunohistochemistry market are F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Eagle Biosciences, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S), Cell Signaling Technology, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Bio SB Inc. (U.S.), Biocare Medical, LLC. (U.S.), Bio-Genex Laboratories (U.S.), and CANDOR Bioscience GmbH (Germany).

Among all the offerings studied in this report, in 2024, the consumables segment is expected to account for the largest share of 68.4% of the immunohistochemistry market. The large market share of this segment is attributed to the advancements in kits and reagents enabling laboratories to perform multiple tests simultaneously, the rising burden of chronic diseases, and growing research in genetic and rare diseases by biopharmaceutical companies, contract research organizations, and research laboratories.

Among all the methods studied in this report, in 2024, the avidin-biotin complex is expected to account for the largest share of 30.8% of the immunohistochemistry market. The large market share of this segment is attributed to the various advantages of avidin-biotin complexes, such as resistivity to enzymatic reactions, change in pH, temperature, denaturation, and organic reagents, increased detection efficiency, low primary antibody consumption, and less assay time as compared to other methods.

Among all the applications studied in this report, in 2024, the clinical applications segment is expected to account for the largest share of the immunohistochemistry market. The segment's large market share can be attributed to the rising burden of cancer, the rising awareness of the advantages of immunohistochemistry testing for treatment purposes among healthcare professionals, and the increasing number of diagnostic laboratories. For instance, according to the American Cancer Society, around 20 million new cancer cases were newly diagnosed, and 9.7 million individuals died from the cancer worldwide in 2022. The number of cases is expected to reach up to 35 million by 2050. This increases the demand for immunohistochemistry tests for disease detection.

Among all the end users studied in this report, in 2024, the hospitals and diagnostic laboratories segment is expected to account for the largest share of the immunohistochemistry market. This segment's largest share is attributed to the increasing incidences of cancer, high healthcare expenditures, and the increasing number of hospitals in both developed and developing countries. Furthermore, patients' inclination toward hospitals due to well-established infrastructure, availability of skilled professionals, medical facilities, and advanced treatments also support the large market share of hospitals and diagnostic laboratories.

An in-depth analysis of the geographical scenario of the global immunohistochemistry market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Asia-Pacific is projected to register the highest CAGR of 13.0% during the forecast period. Accelerated growth in emerging countries in Asia-Pacific has relatively increased the emphasis of various governments towards the healthcare sector in terms of increased investments to enhance the accessibility to healthcare facilities and build better healthcare infrastructure.

Scope of the Report:

Immunohistochemistry Market Assessment-by Offering

Consumables
- Reagents
Fixation Reagents
Antigen Retrieval
Buffers
Blocking Reagents
Antibodies
Control Reagents
Chromogenic Substrates
Counterstain
- Other accessories
Equipment
- Staining Systems
- Imaging Systems
- Slide Scanners
- Tissue Microarrays
Services & Software

Note: other accessories include glass slides, racks & vials, mounting media, and organic solvents.

Immunohistochemistry Market Assessment-by Method

Avidin-Biotin Complex
Polymer-Based Immunohistochemistry
Catalyzed Signal Amplification (CSA)
Fluorescyl-tyramide Amplification
Improved Catalyzed Signal Amplification (iCSA)
Multi-Staining Immunohistochemistry
Labeled Streptavidin Biotin (LSAB)
PAP Method

Immunohistochemistry Market Assessment-by Process

Sample Preparation
Antigen Retrieval
Background Blocking
Target Detection
Sample Visualization

Immunohistochemistry Market Assessment-by Application

Research and Other Applications
- Drug Discovery
- Agriculture & Animal Research
- Other Applications
Clinical Applications
- Reproductive Health
- Oncology
- Infectious Disease
- Other Clinical Applications

Note 1: Other applications include food microbiology, microbiota analysis in the beverage industry, and environmental studies.

Note 2: Other clinical applications include the detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and food-borne illnesses.

Immunohistochemistry Market Assessment-by End User

Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Academic Institutes & Research Centers
Other End Users

Note: Other end users include forensic laboratories and transfusion laboratories.

Immunohistochemistry Market Assessment-by Geography

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K
- Italy
- Spain
- Rest of Europe (RoE)
Asia-Pacific (APAC)
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific (RoAPAC)
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa

1. Introduction

1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Process of Data Collection & Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecasting
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
- 2.3.3. Market Share Analysis
2.4. Assumptions for the Study

3. Executive Summary

4. Factors Affecting Market Growth

4.1. Overview
4.2. Drivers
- 4.2.1. Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population
- 4.2.2. Increasing Focus on Rare Disease
- 4.2.3. Rising Awareness Regarding Early Disease Diagnosis
- 4.2.4. Increasing Research and Development Expenditure
- 4.2.5. Rising Demand for Drug Discovery and Development
- 4.2.6. Rising Prevalence of Infectious Diseases
- 4.2.7. Increasing Funding for Research Activities
- 4.2.8. Rising Healthcare Expenditure
4.3. Restraints
- 4.3.1. Lack of Standardized Protocols
4.4. Opportunities
- 4.4.1. Increasing Inclination Toward Personalized Medicine
- 4.4.2. Advancements in Genomics and Proteomics
- 4.4.3. Increasing Automation in Immunohistochemistry
4.5. Challenges
- 4.5.1. Availability of Alternative Technology
4.6. Trends
- 4.6.1. AI-Based Histochemistry
- 4.6.2. Use of Multiplex IHC
4.7. Factor Analysis
4.8. Case Studies
4.9. Pricing Analysis
4.10. Regulatory Analysis
- 4.10.1. U.S.
- 4.10.2. Canada
- 4.10.3. Europe
- 4.10.4. China
- 4.10.5. Japan
- 4.10.6. India
- 4.10.7. Latin America
- 4.10.8. Middle East
4.11. Pricing Analysis
4.12. Porter's Five Forces Analysis

5. Immunohistochemistry Market Assessment-by Offering

5.1. Overview
5.2. Consumables
- 5.2.1. Reagents
  - 5.2.1.1. Fixation Reagents
  - 5.2.1.2. Antigen Retrieval
  - 5.2.1.3. Buffers
  - 5.2.1.4. Blocking Reagents
  - 5.2.1.5. Antibodies
  - 5.2.1.6. Control Reagents
  - 5.2.1.7. Chromogenic Substrates
  - 5.2.1.8. Counterstain
- 5.2.2. Other Accessories
5.3. Equipment
- 5.3.1. Staining System
- 5.3.2. Imaging Systems
- 5.3.3. Slide Scanners
- 5.3.4. Tissue Microarrays
5.4. Services & Software

6. Immunohistochemistry Market Assessment-by Method

6.1. Overview
6.2. Avidin-Biotin Complex
6.3. Polymer-Based Immunohistochemistry
6.4. Catalyzed Signal Amplification (CSA)
6.5. Fluorescyl-tyramide Amplification
6.6. Improved Catalyzed Signal Amplification (iCSA)
6.7. Multi-Staining Immunohistochemistry
6.8. Labeled Streptavidin Biotin (LSAB)
6.9. PAP Method

7. Immunohistochemistry Market Assessment-by Process

7.1. Overview
7.2. Sample Preparation
7.3. Antigen Retrieval
7.4. Background Blocking
7.5. Target Detection
7.6. Sample Visualization

8. Immunohistochemistry Market Assessment-by Application

8.1. Overview
8.2. Research and Other Applications
- 8.2.1. Drug Discovery
- 8.2.2. Agriculture & Animal Research
- 8.2.3. Other Applications
8.3. Clinical Applications
- 8.3.1. Reproductive Health
- 8.3.2. Oncology
- 8.3.3. Infectious Disease
- 8.3.4. Other Clinical Applications

9. Immunohistochemistry Market Assessment-by End User

9.1. Overview
9.2. Pharmaceutical & Biotechnology Companies
9.3. Hospitals & Diagnostic Laboratories
9.4. Academic Institutes & Research Centers
9.5. Contract Research Organizations
9.6. Other End Users

10. Immunohistochemistry Market Assessment-by Geography

10.1. Overview
10.2. North America
- 10.2.1. U.S.
- 10.2.2. Canada
10.3. Europe
- 10.3.1. Germany
- 10.3.2. France
- 10.3.3. U.K.
- 10.3.4. Italy
- 10.3.5. Spain
- 10.3.6. Rest of Europe
10.4. Asia-Pacific
- 10.4.1. Japan
- 10.4.2. China
- 10.4.3. India
- 10.4.4. Australia
- 10.4.5. South Korea
- 10.4.6. Rest of Asia-Pacific
10.5. Latin America
- 10.5.1. Brazil
- 10.5.2. Mexico
- 10.5.3. Rest of Latin America
10.6. Middle East & Africa

11. Competition Analysis

11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
- 11.4.1. Industry Leaders
- 11.4.2. Market Differentiators
- 11.4.3. Vanguards
- 11.4.4. Emerging Companies
11.5. Market Share Analysis/Market Rankings of Key Players (2023)

12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

12.1. F. Hoffmann-La Roche Ltd (Switzerland)
12.2. Danaher Corporation (U.S.)
12.3. Agilent Technologies, Inc. (U.S.)
12.4. Merck KGaA (Germany)
12.5. Bio-Rad Laboratories, Inc. (U.S.)
12.6. Eagle Biosciences, Inc. (U.S.)
12.7. Thermo Fisher Scientific Inc. (U.S)
12.8. Cell Signaling Technology, Inc. (U.S.)
12.9. PerkinElmer, Inc. (U.S.)
12.10. Bio SB Inc. (U.S.)
12.11. Biocare Medical, LLC. (U.S.)
12.12. Bio-Genex Laboratories (U.S.)
12.13. CANDOR Bioscience GmbH (Germany)
12.14. Innovex Biosciences Inc. (U.S.)

(Note: SWOT analysis of the top 5 companies will be provided.)

13. Appendix

13.1. Available Customization
13.2. Related Reports